Lisanti Capital Growth, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Lisanti Capital Growth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$83.14 - $145.99 $6.31 Million - $11.1 Million	-75,947 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $905,187 - $1.18 Million	-8,223 Reduced 9.77%	75,947 $9.01 Million
Q4 2021 Feb 04, 2022	SELL	$99.73 - $148.48 $110,700 - $164,812	-1,110 Reduced 1.3%	84,170 $11.6 Million
Q3 2021 Nov 03, 2021	BUY	$98.85 - $138.91 $8.43 Million - $11.8 Million	85,280 New	85,280 $11.8 Million
Q4 2020 Feb 10, 2021	SELL	$65.07 - $98.24 $6.08 Million - $9.19 Million	-93,498 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$59.04 - $77.95 $2.27 Million - $3 Million	38,443 Added 69.83%	93,498 $6.08 Million
Q2 2020 Aug 10, 2020	BUY	$29.01 - $74.23 $1.6 Million - $4.09 Million	55,055 New	55,055 $4.03 Million
Q1 2020 May 11, 2020	SELL	$27.51 - $57.29 $412,374 - $858,777	-14,990 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $612,491 - $864,173	14,990 New	14,990 $816,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.58B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.